Sleep disturbances in highly stress reactive mice: Modeling endophenotypes of major depression by Fenzl, Thomas et al.
RESEARCH ARTICLE Open Access
Sleep disturbances in highly stress reactive mice:
Modeling endophenotypes of major depression
Thomas Fenzl
1*†, Chadi Touma
1†, Christoph PN Romanowski
1, Jörg Ruschel
2, Florian Holsboer
1, Rainer Landgraf
1,
Mayumi Kimura
1, Alexander Yassouridis
1
Abstract
Background: Neuronal mechanisms underlying affective disorders such as major depression (MD) are still poorly
understood. By selectively breeding mice for high (HR), intermediate (IR), or low (LR) reactivity of the hypothalamic-
pituitary-adrenocortical (HPA) axis, we recently established a new genetic animal model of extremes in stress
reactivity (SR). Studies characterizing this SR mouse model on the behavioral, endocrine, and neurobiological levels
revealed several similarities with key endophenotypes observed in MD patients. HR mice were shown to have
changes in rhythmicity and sleep measures such as rapid eye movement sleep (REMS) and non-REM sleep (NREMS)
as well as in slow wave activity, indicative of reduced sleep efficacy and increased REMS. In the present study we
were interested in how far a detailed spectral analysis of several electroencephalogram (EEG) parameters, including
relevant frequency bands, could reveal further alterations of sleep architecture in this animal model. Eight adult
males of each of the three breeding lines were equipped with epidural EEG and intramuscular electromyogram
(EMG) electrodes. After recovery, EEG and EMG recordings were performed for two days.
Results: Differences in the amount of REMS and wakefulness and in the number of transitions between vigilance states
were found in HR mice, when compared with IR and LR animals. Increased frequencies of transitions from NREMS to
REMS and from REMS to wakefulness in HR animals were robust across the light-dark cycle. Detailed statistical analyses
of spectral EEG parameters showed that especially during NREMS the power of the theta (6-9 Hz), alpha (10-15 Hz) and
eta (16-22.75 Hz) bands was significantly different between the three breeding lines. Well defined distributions of
significant power differences could be assigned to different times during the light and the dark phase. Especially during
NREMS, group differences were robust and could be continuously monitored across the light-dark cycle.
Conclusions: The HR mice, i.e. those animals that have a genetic predisposition to hyper-activating their HPA axis
in response to stressors, showed disturbed patterns in sleep architecture, similar to what is known from depressed
patients. Significant alterations in several frequency bands of the EEG, which also seem to at least partly mimic
clinical observations, suggest the SR mouse lines as a promising animal model for basic research of mechanisms
underlying sleep impairments in MD.
Background
As an adaptation to the regular day/night cycles, organ-
isms synchronize their physical activities, energy meta-
bolism, immune functions and sleep by means of a
circadian clock system [1-3]. In addition, individuals
continuously face unforeseen short- and long-term
changes in the environment called ‘’stressors’’,w h i c h
can be physical or psychological [4,5]. To adapt to these
stressful stimuli, another regulatory system, the stress
system, has evolved which senses environmental changes
through various sensory organs, processes them in the
central nervous system (CNS) and adjusts the CNS and
peripheral organ activities to improve chances for survi-
val in nature [6-8]. The major system regulating internal
homeostasis is the hypothalamic-pituitary-adrenal (HPA)
axis, which accounts for circadian activity and mediates
the adaptive response to stressors (see reviews cited
above).
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for survival and thus communicate with one another at
multiple levels to adjust numerous physiological activ-
ities [1,9-11]. Importantly, dysregulation in either of
these systems can lead to similar pathologic conditions,
including sleep-related problems and mood disorders
such as major depression (MD) [10,12-14].
Therefore, it is not surprising that sleep disturbances
are among the most common symptoms of MD and
characteristic sleep electroencephalographic (EEG)
alterations are one of the most robust predictors of an
emergent depressive episode [13,15-17]. Compared to
healthy subjects, EEG recordings, which allow to objec-
tively assessing sleep structure alterations, revealed that
MD patients often suffer from insomnia and sleep frag-
mentation. They also show a reduced latency to the first
episode of REMS, an increased proportion of REMS
(increased REMS density) and reduced slow-wave activ-
ity (SWA) during NREMS [12,13,16,18]. Most changes
of the sleep EEG pattern prevalent during a depressive
episode are moderated or even disappear following suc-
cessful treatment. Those patients where these sleep EEG
abnormalities persist, despite their full clinical remission
are at increased risk for relapse into another disease epi-
sode [19-21]. Furthermore, healthy high-risk probands
with a positive family history of affective disorders also
have been found to show an increased REM density,
indicating that some of the sleep EEG changes might
represent neurobiological vulnerability markers or endo-
phenotypes of the disease [22,23].
Another biological hallmark of MD is a dysregulation
of the HPA axis (hyper- or hypo-activity), largely invol-
ving pathological alterations in the corticotrophin-
releasing hormone (CRH) system [6,13,17,24-27].
Common neuroendocrine symptoms of severely
depressed patients include a flattened diurnal rhythm of
glucocorticoid (GC) secretion, elevated plasma GC con-
centrations (hypercortisolism) and adrenal hyperplasia
[28-31]. Furthermore, dysfunctional GC receptor-
mediated negative feedback regulation of the HPA axis
and changes in vasopressin and CRH responsiveness
have frequently been described (see reviews cited
above). However, it is increasingly acknowledged that
the diagnosis of MD encompasses patients, who do not
necessarily share the same disease biology, supporting
the concept that depression needs to be differentiated
accordingly to different causal mechanisms [13,25,
26,32,33]. For instance, HPA axis overdrive, related to
an enhanced secretion of CRH and an impaired negative
feedback via GC receptors, is most consistently observed
in patients with psychotic depression. These patients
also show the most pronounced sleep-EEG alterations,
including disrupted sleep, decreased SWA and short
REMS latency. In contrast, patients suffering from the
so-called atypical subtype of depression are charac-
terised by markedly reduced activity of the HPA axis,
while sleep-EEG data suggest that SWA is not reduced
and REMS parameters are not considerably altered in
these patients [13,32].
Based on the vital link between stress sensitivity and
the development of MD [6,17,24,27,34], a new genetic
animal model has recently been established, focusing on
alterations in HPA axis reactivity as one of the major
endophenotypes in depressed patients [35]. This
so-called ‘stress reactivity’ (SR) mouse model consists of
three separate breeding lines selected for either high
(HR), intermediate (IR), or low (LR) corticosterone
increase in response to a moderate psychological stres-
sor (15-min restraint). Significant differences in the
reactivity of the HPA axis between HR, IR (independent
“control"-line) and LR mice were already found in the
first generation of the selective breeding process and
proved to be a highly heritable trait, i.e. the respective
phenotype was confirmed across all subsequent genera-
tions and could even be increased by assortative breed-
ing [35]. Moreover, results of an extensive behavioral
test battery applied to the selected mouse lines as well
as neuroendocrine characterisation experiments revealed
several phenotypic similarities with changes observed in
depressive patients [35-38]. In general, HR animals
showed cognitive deficits, particularly in hippocampus-
dependent tasks, and were relatively hyperactive in some
behavioral paradigms, resembling symptoms of restless-
ness and agitation often seen in psychotic and melan-
cholic depression [35,36,38]. LR mice, on the other
hand, showed clearly more passive coping styles, corre-
sponding to signs of retardation and retreat observed in
atypical depression [35]. Furthermore, we found that
hyper-responsiveness to stressors was associated with
rhythmicity changes (increased physical activity towards
the end of the resting period), resembling symptoms
like restlessness, sleep continuity disturbances and early
awakenings that are commonly seen in psychotic and
melancholic MD patients [37]. Additionally, HR mice
also showed neuroendocrine abnormalities similar to
symptoms of MD patients such as reduced amplitude of
the circadian GC rhythm and elevated trough levels
[35,37]. Sleep-EEG analyses, furthermore, revealed
c h a n g e si nR E M Sa n dN R E M Sa sw e l la sS W A ,i n d i c a -
tive of reduced sleep efficacy and REMS disinhibition in
HR mice [37].
Therefore, in the present study we were interested in
how far a detailed spectral analysis of several frequency
bands, including a sophisticated event history analysis
[39], could reveal further alterations in the sleep archi-
tecture of this animal model of affective disorders. This
is of particular interest, as such an in-depth analysis of
sleep characteristics is often used in human MD patients
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not been applied to characterise sleep in a genetic ani-
mal model for extremes in HPA axis reactivity. Thus,
our data can contribute to understanding the basic
mechanisms underlying sleep disturbances associated
with HPA axis dysfunctions and could ultimately be
used to elucidate the pathophysiology of sleep impair-
ments in MD patients, including the development of
new treatment options for the disorder.
Results
The evaluation of individual vigilance states revealed a
typical circadian distribution of the normed durations of
WAKE, NREMS and REMS across the recording session
in all three breeding lines (Figure 1). During the light
periods L1 (ZT0-6) and L2 (ZT6-12), all animals spent
more time in NREMS than in WAKE, while especially
during the first half of the dark period D1 (ZT12-18) all
animals were more awake. During L1, significant group
differences were found for REMS among HR, LR and IR
animals (F(2,20) = 9.535; p = 0.006). Post hoc tests
revealed a significantly increased amount of REMS in
HR mice, when compared with IR and LR animals (Bon-
ferroni modified LSD-Tests, p < 0.05). In L2, significant
group effects were found for all three vigilance states,
i.e. WAKE (F(2,20) = 6.108; p = 0.03), NREMS (F(2,20) =
6.108; p = 0.01) and REMS (F(2,20) = 6.108; p = 0.008).
Whereas for WAKE the significant group effects were
caused only by the differences between HR and LR, for
NREMS and REMS the group effects derived from sig-
nificant differences among all three breeding lines (Bon-
ferroni modified LSD-Tests, p < 0.05). During D1, no
differences in mean durations could be found between
the groups. During D2, however, strong group differ-
ences were found for REMS (F(2,20) = 5.573; p = 0.012).
As expected, the most transitions were found between
WAKE and NREMS and vice versa (Figure 2, L1 - D2).
The detailed analysis of the normed transition frequen-
cies calculated for each breeding line revealed significant
differences in L2 between REMS and WAKE (F(2,20) =
5.163; p = 0.016; HR vs. IR and LR) and in D1 between
REMS and WAKE (F(2,20) = 4.316; p = 0.028). In
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Figure 1 Mean duration of vigilance states in high reactivity (HR), intermediate reactivity (IR) and low reactivity (LR) mice. The relative
amounts of WAKE, NREMS and REMS are plotted in the panels L1 (light period 1, ZT0-6), L2 (light period 2, ZT6-12), D1 (dark period 1, ZT12-18,
dark background) and D2 (dark period 2, ZT18-23, dark background). All three mouse lines display a typical circadian distribution of the vigilance
states with significant differences observed in the HR line compared to IR and LR mice. Statistical differences between the mouse lines are
indicated by asterisks ((*), Bonferroni modified LSD tests, p < 0.05). Data are given as means ± SEM.
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Page 3 of 12general, the fewest transitions were detected between
REMS and WAKE (Figure 2, L1 - D2; HR vs. IR and
LR). In the time interval D2 group comparisons revealed
significant effects on the transition frequencies, which
were considerable regarding NREMS to WAKE (F(2,20) =
6.632; p = 0.006), REMS to WAKE (F(2,20) =7 . 3 2 2 ;p=
0.004) and less pronounced regarding WAKE to
NREMS (F(2,20) =3 . 8 9 3 ;p=0 . 0 3 7 )a n dN R E M St o
REMS (F(2,20) =5 . 6 2 4 ;p=0 . 0 1 2 ) .T h e s et r a n s i t i o n s
showed significant differences preponderantly between
HR and LR animals (Bonferroni modified LSD-Tests,
p < 0.05). The increased duration of REMS in HR ani-
mals, shown in Figure 1 was not a consequence of an
overall increased REMS episode length (Figure 3, for L1:
F(2,20) = 1.339; p = 0.287, for L2: F(2,20) = 0.173; p =
0.843, for D1: F(2,20) = 0.517; p = 0.605 and for D2:
F(2,20) = 0.518; p = 0.604) but rather due to an increased
number of transitions from NREMS into REMS and
back from REMS towards WAKE.
After addressing a stability hypothesis on continuity
parameters (please refer to the methods section) for
particular frequency bands in NREMS (Figure 4, left col-
umn), we found that the power of the theta (6-9 Hz) -
and alpha-band (10-15 Hz) in LR animals was stable
and continuously below the corresponding powers of
the other two breeding lines (Wilcoxon matched paired
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Figure 2 Mean transition frequencies between the three vigilance states in HR, IR and LR mice. The relative amounts of transition
frequencies for all vigilance states are plotted separately for L1, L2, D1 and D2. In L2 and D1, the HR animals had significantly more transitions
from REMS to WAKE, when compared with both other lines. In D2, the HR line showed a different pattern of transitions for all combinations
shown, when compared with IR and LR mice, except for the transition of REMS to NREMS. Statistical differences between the mouse lines are
indicated by asterisks (*). Data are given as means ± SEM.
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Page 4 of 12test, p < 0.05). At the eta-band (16-22.75 Hz), a stable
differentiation could only be observed between HR and
IR animals. For all other frequency bands, no continu-
ously stable differentiations were found, neither in
WAKE nor during REMS. After testing the stability
on continuity parameters for particular transitions
(Figure 4, right column), we found that the frequencies
of transitions from NREMS to REMS and from REMS
to WAKE in HR animals were stable and continuously
above the corresponding transition frequencies of IR
a n dL R( W i l c o x o nm a t c h e dp a i r e dt e s t ,p<0 . 0 5 ) .A l l
other possible transitions revealed no significantly differ-
ent continuity parameters.
Further, we were interested in the distribution of the
power of delta (0.75-5 Hz) -, theta-, alpha-, eta- and
beta (23-31.75 Hz) -frequency bands in all three breed-
ing lines. Without differentiating between WAKE,
NREMS and REMS, during L1 (Figure 5) the mean
power of the alpha band revealed a significant group
effect (F(10,32) = 3.94; p = 0.001), which was attributed to
significant differences between HR and LR animals
(Bonferroni modified LSD tests, p < 0.05). In L2, the
power of the eta band significantly differed between all
three groups (F(10,32) = 3.99; p = 0.001). Post-hoc Bon-
ferroni tests revealed significant differences solely
between HR and IR mice. Whereas in the first six hours
of the dark period (D1), no significant differences in any
of the considered power spectra appeared, with the
power of the theta band within the second half of the
dark period (D2) revealing significant distinctions
between HR, LR and IR animals (F(10,32) =3 . 1 5 ;p=
0.007). These differences were detected between HR and
LR animals and between IR and LR mice (Bonferroni
modified LSD tests, p < 0.05).
Additionally, we examined the distribution of the
power of delta-, theta-, alpha-, eta- and beta-frequency
bands determined in all three breeding lines separately
for NREMS and REMS. When considering NREMS dur-
ing L1, significant effects in several spectra were found
between the groups (F(10,32) = 3.72; p = 0.002), which
were attributed to clear group differences in the theta-,
alpha- and eta-band (univariate F-tests in MANOVA).
F o rt h ep o w e ro ft h e s eb a n d s ,t h eH Ra n dL Ra n i m a l s
showed significant differences. Differences were also
detected between IR and LR animals, but only for the
power of the eta-band (Bonferroni modified LSD tests, p
< 0.05). During L2, the power of the spectra in NREMS
revealed also significant group differences (F(10,32) =
4.22; p = 0.001), caused mostly by the significant differ-
ences between HR and LR in the theta-band and
between IR and LR in the eta-band (Bonferroni modified
LSD tests, p < 0.05). During D1, differences could only
be detected for the theta-band (F(10,32) =3 . 5 6 ;p=
0.003) between HR and LR mice (Bonferroni corrected).
Finally, during D2 group comparisons revealed also a
significant effect on the spectral powers (F(10.32) = 4.57;
p < 0.001), which was profound regarding the power of
the theta and alpha bands (univariate F tests in MAN-
OVA, p < 0.05). The changes in these power spectra
were caused by the distinctions between HR and LR for
the theta-band and between HR and LR for the alpha-
band (Bonferroni modified LSD tests, p < 0.05). When
considering all power spectra separately during REMS,
we did not find any significant group differences
throughout all four time periods L1-D2.
Discussion
The stress reactivity (SR) mouse model was established
as a new mouse model for affective disorders comprising
neuroendocrine core symptoms such as a hyperreactive
HPA axis, frequently observed in depressed patients
[35]. In the present study, we provide evidence support-
ing the establishment of the SR model as a promising
animal model of major depression, especially when the
attention is drawn towards disturbed sleep as one of the
clinical hallmarks in major depression.
General sleep/wake behavior
Our experiments showed that all three breeding lines of
t h eS Rm o d e l ,n a m e l yt h eH R ,I Ra n dL Rl i n eh a v ea
typical distribution of sleep and wakefulness across the
light/dark cycle with increased amounts of sleep during
the light period and of wakefulness and activity during
the dark period (Figure 1). This typical sleep/wake pat-
tern was shown for mice in numerous studies. To our
knowledge, one of the first studies which investigated
this behavior systematically in several nocturnal rodents
showed that the sleep time in Mus musculus was dis-
tributed differentially during the two phases of the light
cycle, with more sleep during the light than during the
dark phase [40].
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Figure 3 Mean REMS episode length in HR, IR and LR mice.
Group-comparisons for all three breeding lines during L1, L2, D1
and D2 revealed no significant differences for the mean REMS
episode length. Data are given as means ± SEM.
Fenzl et al. BMC Neuroscience 2011, 12:29
http://www.biomedcentral.com/1471-2202/12/29
Page 5 of 12The present analysis of the sleep/wake behavior in the
SR model (Figure 1) revealed significant differences
between the three breeding lines, especially increased
amounts of REMS for the HR line during the resting
period and the second half of the active period. For HR
mice increased GC concentrations during the entire
light period as well as at the end of the dark period
were shown [37], pointing towards an increased HPA
axis activity. It was shown in several studies that CRH,
one major player of the HPA axis, can promote REMS.
In rats, for example, it was stated that after sleep depri-
vation with the water-tank method, CRH mediating
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Figure 4 Stability of progressions over time in HR, IR and LR mice. Left column: The curve progressions of group means of normalized
power (expressed in percent of the total power) are plotted separately for each breeding line during L1, L2, D1 and D2. The mean theta power
and mean alpha power of the LR animals clearly showed a stable progression significantly below the mean of both frequency bands in HR and
IR mice across the whole experimental time period. Right column: The number of transitions from NREMS to REMS and from REMS to WAKE in
HR mice are significantly and robust above the transitions of IR and LR animals. Data are given as means without SEM for reasons of clarity.
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Page 6 of 12stress could be the main factor inducing a REMS
rebound [41] and suppression of slow wave sleep (SWS)
[42,43]. In mice, which conditionally and CNS-restricted
over-express CRH, enhanced REMS was attributed to an
enhanced CRH secretion [44]. These authors also stated
that elevated REMS may serve as a premorbid precursor
of hypersecreted CRH predicting a clinical condition
such as depression. Similar findings were reported in
clinical studies, where the disinhibition of REMS during
depression was assigned to a synergism of elevated CRH
and cortisol activity [45]. Interestingly, CRH and CRH
receptor type 1 and 2 agonists are able to either
decrease [46-48] or increase [49] the amount of REMS
in both rats and mice. It was concluded that the fragile
vigilance state of REMS may be influenced by CRH in
opposite directions, depending on the experimental
design [46]. Our data from HR mice with a hyperreac-
tive HPA axis also support the notion that elevated
REMS is a sign of increased activity of the CRH system.
Increased secretion of CRH in HR animals may also
contribute to increased levels of wakefulness in HR ani-
mals during the second half of the light period. In rats,
restraint stress during the light period resulted in pro-
longed wakefulness, while CRH receptor antagonists
blocked the increase in waking [50]. The reduction of
physiologically active CRH levels through application of
CRH antisense oligodeoxynucleotides under stress-free
conditions led to a reduction in wakefulness, and it was
concluded that CRH is involved also in the modulation
of spontaneous awaking [51].
The increased amount of REMS in HR mice could not
simply be attributed to more REMS per se,a sa
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Figure 5 Mean relative power of the EEG frequency bands in HR, IR and LR mice. The relative power, summarized for the vigilance states
WAKE, NREMS and REMS are plotted separately for L1, L2, D1 and D2. Significant differences in particular frequency bands are highlighted with
a striped background (L1: alpha-band at 10-15 Hz; L2: eta-band at 16-22.75 Hz and D2: theta-band at 6-9 Hz). Marginal differences are marked
with a dotted background (L1: theta-band at 6-9 Hz and eta-band at 16-22.75 Hz; D1: theta-band at 6-9 Hz). Data are given as means without
SEM for reasons of clarity.
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Page 7 of 12comparison of the mean REMS episode length revealed
no significant differences in all four experimental time
periods L1-D2 (Figure 3). Rather, the HR line had an
increased transition frequency into REMS (from
NREMS, although only significant during D2) and from
REMS towards wakefulness (Figure 2). These differences
in sleep architecture may be partly due to REMS pro-
moting effects of CRH, as discussed above. Accordingly,
CRH does not act on duration of REMS episodes but on
their amount, leading to an instable and fragmented bal-
ance between REMS and wakefulness (Figure 2). Similar
sleep alterations were found in a different mouse model
of depression. Mice selectively bred for high sponta-
neous helplessness in the tail suspension test showed
enhanced REMS pressure and fragmented sleep [52].
Hyperactivity of the HPA axis, which is observed in
depressed patients [53,54], may have been responsible
for these physiological changes in sleep/wake behavior,
as the helpless mice had elevated serum corticosterone
levels [52]. In humans, a causal coherence between
impaired sleep and HPA axis hyperactivity was also sug-
gested in the melancholic subtype of depression [45,55].
The increased number of transitions from NREMS to
REMS and especially from REMS towards wakefulness
in HR animals were consistently above the number of
transitions in IR and LR mice across the entire record-
ing time (Figure 4). This points towards a robust pheno-
type within the sleep architecture of HR animals
supporting the applicability of the SR mouse model to
mimic sleep impairments in depression such as frag-
mented sleep.
Theta enhancement in HR mice
The theta frequency (6-12 Hz, according to different
authors) represents the dominant oscillation during
REMS [56-59]. It strongly depends on inhibitory
GABAergic and excitatory acetylcholinergic inputs from
the medial septum into the hippocampus [56,60]. It has
been shown that CRH can modulate cholinergically dri-
ven hippocampal theta frequency [61] or even enhance
theta amplitude and frequency [62]. Interestingly,
although the cholinergic and the CRH system seem to
interact, CRH enhanced pharmacologically induced cho-
linergic blockades, leading to impairments during spatial
learning [63]. Increased amounts of CRH may, on the
one hand, be responsible for enhanced theta activity in
HR animals, compared to LR mice (Figure 5), probably
causing deficits of HR animals in object memory and
spatial memory tasks [38]. Partly not in accordance with
this are findings that, although IR animals had increased
theta activity, compared to LR mice but not to HR ani-
mals (Figure 5), this breeding line did show only inter-
mediate levels of corticosterone when all three lines (HR
v s .I Rv s .L R )w e r ec o m p a r e d[ 3 5 ]a n ds p a t i a lm e m o r y
performance in IR was not as affected as in HR mice
[38]. Although it is well established that patients with
major depression show cognitive impairments [64,65],
such symptoms often outlast a recovery from psycho-
pathological symptoms and it seems unlikely that solely
hypercortisolism causes these disabilities [66]. It will
need to be clarified, in how far cognitive impairments
are due to hypercortisolemia-induced long-term changes
in relevant brain regions such as the hippocampus [66].
In general, the above outlined interpretation of our data
must be critically evaluated in future experiments, since
theta enhancement in HR mice may have also been
partly caused simply by increased amounts of wakeful-
ness (Figure 1, L2) and REMS (Figure 1, L1, L2 and D2).
Differentiated alpha frequencies
Cortico-cortical and thalamo-cortical circuits were
thought to provide neuronal origins of oscillatory EEG
alpha activity [67,68]. More recent publications attribute
the alpha band to interconnected populations of layer V
neurons from the occipital cortex [69].Modulation of
these generators may be realized at the thalamic level,
induced by the reticular activating system within the
brainstem [70]. The locus coeruleus (LC), as part of the
reticular activating system projects to the thalamus
(additionally to the forebrain, cortex and hypothalamus)
and activation through CRH leads to an increase in EEG
frequency, decreased SWS (0.5-4.5 Hz) and increased
wakefulness [71,72].Interestingly, LC neurons also dis-
charge maximally during stressful conditions through
local release of CRH [73-75].
Increased alpha bands were not only present in HR
animals during the first half of the light period, but also
in humans in conjunction with depression [76]. These
authors classified participants in their study in a high vs.
low depression group, according to their scores on two
different inventories and found that high depression par-
ticipants had more alpha activity (8-13 Hz) in frontal
and parietal regions of the EEG. As predicted for
depression, when differentiating between the two hemi-
spheres of the cortex, less right frontal alpha activity
was associated with better memory performance in the
low depression group [76] (for the relationship between
hemispheric EEG-asymmetry and different aspects of
emotion, refer to e.g. [77]). Increased alpha activity in
HR animals, when compared with LR animals may also
contribute to memory deficits found in HR mice, thus
supporting the notion that the SR model is a promising
animal model for cognitive deficits in depression [36,38].
Increased eta power in HR mice
Moreover, we found that HR animals had increased eta
power (16-22.75 Hz) during the second half of the light
period. The eta band as investigated in our study
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described as beta band in literature (beta can range from
12 Hz to 35 Hz, depending on individual settings of the
experimenter and the species under investigation). His-
torically, the beta band was set at 12-30 Hz [78]. We
introduced the eta band in earlier studies to specify the
delta and the beta band during data analysis according to
the species-specific EEG of mice (for a precise descrip-
tion of the algorithm, refer to [79]), as opposed to the
suggested specifications for rats [80]. The narrow specifi-
cation of our eta band is hardly found in the literature,
when oscillations are discussed; thus, every conclusion
from our data on increased eta power would be specula-
tive. Interestingly enough, in humans faster frequencies
(the authors defined beta as 14.75-30 Hz) were stated to
be indicative of cortical arousal [81], supporting the CNS
hyperarousal hypothesis for insomnia [82,83], and beta-2
oscillations (20-30 Hz, as stated by the authors), recorded
from the somatosensory and motor cortices were coher-
ent with muscle electrical activity [81]. Our data on
increased eta activity (as part of beta) during L2 in HR
mice (Figure 5) may be linked to the increased wakeful-
ness detected during L2 (Figure 1).
Stability of data across recordings
The robustness of the above described theta, alpha and
eta differences were predominantly found during
NREMS with high stability across the whole recording
time (Figure 4), whereas no robust differences for these
frequency bands could be observed during REMS (data
not shown). It is tempting to speculate that HR mice
with robustly increased alpha and eta power, although
not dramatically more awake than IR and LR mice dur-
ing L1-D2 have a shallower NREMS. This is in accor-
dance with clinical studies describing shallow sleep in
depressed patients [45,84]. The stability in the progres-
sion of increased theta power in HR mice across the
whole recording period (Figure 4) could, at least partly,
explain the increased amounts of REMS during L1, L2
and D2, also mirrored in the increased transition fre-
quencies from REMS to wakefulness in L2, D1 and D2.
In contrary to increased theta, over time robustly
reduced amounts of this frequency band, as detected in
LR animals may serve as a driving force to decrease
REMS.
I ng e n e r a l ,t h eb e t aa n dd e l t ab a n d sa r ev e r ym u c h
parallel among humans and primates, but one has to be
very critical in transferring findings from a rodent EEG
to a human EEG, especially for the alpha and theta
bands.
Conclusions
HR mice, i.e. those animals that have a genetic predispo-
sition for hyper-activating their HPA axis in response to
restraint stress, showed altered sleep architecture, simi-
lar to what is known from depressed patients. Moreover,
robust differences along the activities of several fre-
quency bands of the EEG, which also seem to at least
partly mimic clinical observations, suggest the stress-
reactivity mouse model understanding the mechanisms
underlying sleep impairments in patients suffering from
stress-related diseases. The herein reported findings also
underscore the notion that sleep-EEG measures in
rodents could help to find human biomarkers in the
future which might provide tools to create patient sub-
groups with similar, if not identical disease mechanisms.
Methods
Animals and housing conditions
All animals used in this study derived from the seventh
generation (Gen VII) of the ‘stress reactivity’ (SR) mouse
model [35]. This model was generated from the CD-1
mouse strain and consists of three independent mouse
lines selectively bred for either high (HR), intermediate
(IR) or low (LR) reactivity of the HPA axis (for a
detailed description see [35]. Eight adult males of each
b r e e d i n gl i n e( H R ,L Ra n dI R )w e r eu s e di nt h ee x p e r i -
ment. Each animal was housed separately in an indivi-
dual recording cage located in a sound attenuated
chamber at constant laboratory conditions (23 ± 1°C,
12-12 h light-dark cycles, lights on: 10 am). Food and
water were available ad libitum.
Surgery
An isofluran/oxygen anesthesia (custom made vaporizing
device) was used during all surgical preparations of the
animals. Prior to the surgery, each animal received atro-
pine sulfate (0.05 mg/kg BW) and meloxicam (0.5 mg/kg
BW) subcutaneously. Each animal was surgically
equipped with four epidural electroencephalogram (EEG)
and two intramuscular electromyogram (EMG) electro-
des. A detailed description of the surgeral procedure is
described elsewhere [37,79]. Briefly, to place the EEG
electrodes on the cortex, four small holes were drilled
into the skull preserving the cerebral membrane. Two
electrodes were bilaterally placed at the standard frontal
region of the skull (caudal third of os frontalis), one refer-
ence-electrode was placed at the right standard parietal
area and the ground electrode was inserted at the left
standard parietal area (center of os parietalis). Both fron-
tal electrodes where referenced to the right parietal elec-
trode. The contrallateral lead was analyzed, the ipsilateral
lead only served as additional recording track, if the stan-
dard lead could not be analyzed. Two EMG electrodes
were embedded bilaterally of the spine into the neck
muscles. Postoperative the animals received meloxicam
added to the drinking water (0.5 mg/kg BW). After sur-
gery, the animals were allowed to recover for two weeks
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attached to them before two successive 23 hour recording
sessions of EEG and EMG signals were performed. Each
recording cable was connected to a swivel system allow-
ing free movements of the animal.
Data processing
EEG and EMG signals were fed online into a differential
preamplifier (1000x, custom made) and main amplifier
(10x, custom made). The EEG signals were analog band-
pass filtered (0.5 - 29 Hz, filter frequency roll off 48
dB/octave) and digitized with a sampling rate of 64 Hz
(AD board, NI PCI-6070, National Instruments, Austin,
USA). Root mean square was applied to all non-filtered
EMG signals before its digital conversion (sample rate:
64 Hz). Fast Fourier transform (FFT) for the spectral
analysis was applied on consecutive 4 sec intervals. The
vigilance states WAKE, NREMS and REMS in each of
these intervals were pre-scored semi-automatically with
a LabVIEW-based sleep scoring program (SEA, Koeln,
Germany) and were rescored manually. The frequency
bands applied to the semi-automatic scoring algorhythm
and for statistical quantifications were as follows: delta:
0.75-5 Hz; theta: 6.0-9.0 Hz; alpha: 10.0-15.0 Hz; eta:
16.0-22.75 Hz; beta: 23.0-31.75 Hz. The applied scoring
algorhythm was originally based on experiments with
rats [80]; the eta band was additionally specified in our
experiments [79] to meet the criteria for the slightly dif-
ferent mouse EEG. A detailed description of the scoring
procedure is described elsewhere [79].
Statistical analysis
In general, statistical evaluations and the corresponding
graphs refer to four separate time intervals of the total
recording time: L1 (first half of the light period: ZT0-6
[h]); L2 (second half of the light period: ZT6-12 [h]); D1
(first half of the dark period: ZT12-18 [h]) and D2 (sec-
o n dh a l fo ft h ed a r kp e r i o d :Z T 1 8 - 2 3[ h ] ) .O fp r i m a r y
interest was the investigation of group effects on the
relative stay in the three different vigilance states
(WAKE, NREMS, REMS) as well as on the relative tran-
sition frequencies between the vigilance states within
each of the mentioned time intervals (Note: the relative
stays in WAKE, NREM or REMS refers to the total stay,
which is equal to the length of the considered time
interval and the relative transitions refers to the total
transitions within the corresponding time intervals. Such
relative quantities are often c a l l e dn o r m e dq u a n t i t i e s ) .
G r o u pe f f e c t so nt h en o r m e dd u r a t i o n so fi n d i v i d u a l
vigilance states and normed transition frequencies were
statistically analysed by multivariate analyses of variance
(MANOVAs) for each time interval separately. In cases
of significant main (global) group effects, univariate F
tests followed to identify those variables on which the
group effect was significant. For these variables post-hoc
tests (Bonferroni modified LSD tests) were subsequently
applied for investigating the significance of contrasts or
simple effects i.e. of the differences between group pairs
in the variables showing main group effects. Group
comparisons of the mean REMS episode length were
performed individually for L1-D2 by means of one-way
analyses of variance. For evaluating group differences in
the power of the known frequency bands (delta, theta,
alpha, eta, beta) determining in each of the vigilance
states the area under the curve (AUC) in each time
interval using the trapezoid rule was first calculated and
then analyses of variance were performed.
Finally the assumption that for particular groups the fre-
quency bands across the experimental time lie constantly
over those of other groups (known as stability hypothesis
[85]) was tested for significance with a Wilcoxon
Matched-Pairs Signed-Ranks test by considering the part
of each mean power above the common median at each
time point (ZT1-ZT23). The nominal level of significance
was accepted with p < 0.05. To keep the type I error less
or equal to 0.05, all posteriori tests (univariate F tests, tests
with contrasts) were performed with reduced levels of
significance (adjusted a according to the Bonferroni pro-
cedure). All data are expressed as mean ± SEM.
Animal care
Laboratory animal care and all experimental procedures
were conducted in accordance with the regulations of
the current German Animal Protection Act. The proto-
cols were approved by the Government of Bavaria
(AZ209.1/211-33/04 and AZ55.2/1/54-2531-64/07).
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